...
首页> 外文期刊>Acta oncologica. >Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement
【24h】

Identification and characterization of nodal metastases in prostate cancer patients at high risk for lymph node involvement

机译:淋巴结受累高风险的前列腺癌患者的淋巴结转移的鉴定和表征

获取原文
获取原文并翻译 | 示例
           

摘要

Aim. To investigate whether blood-based markers could be used to identify prostate cancer (PCa) patients harboring lymph node (LN) metastases. In addition, E-cadherin expression was studied within the concept of epithelial mesenchymal plasticity. Material and methods. Seventy-five patients with clinically localized PCa who underwent a superextended lymphadenectomy followed by radical prostatectomy (RP) were included in this study. Preoperative plasma/serum levels of endoglin, transforming growth factor-β1 (TGF-β1), osteopontin, vascular endothelial growth factor (VEGF), vascular cell adhesion molecule-1 (VCAM-1), and E-cadherin were measured using commercially available enzyme immunoassays in 47/75 patients and correlated with clinicopathological parameters. E-cadherin expression in the diagnostic biopsies (n = 63), RP specimens (n = 75) and LN metastases (n = 106) was examined by immunohistochemical analysis. Results. Occult LN metastases were present in almost half of the patients (37/75), with a total of 106 affected LN. Preoperative levels of endoglin, TGF-β1, osteopontin, VEGF, VCAM-1 nor E-cadherin were significantly associated with LN status. Only a positive correlation between plasma endoglin and serum prostate-specific antigen was found (Spearman's r = 0.44; p = 0.002). The majority of biopsies (91.9%) and RP specimens (79.7%) showed strong E-cadherin expression, while in the LN this was found to be much weaker (28.9%). While the staining pattern in the isolated tumor cells (ITC) and micrometastases was mainly homogenous, the macrometastases showed a much more heterogeneous pattern (χ2;, p 0.0001). Conclusion. In this study, none of the blood-based markers tested could be used for nodal staging in PCa, nor could E-cadherin expression in the tissue. However, the difference in E-cadherin expression pattern between the ITC/micrometastases and the macrometastases may point to another biological behavior. The specific staining pattern seen in the macrometastases could indicate an ongoing mesenchymal epithelial transition, presumed to be a mechanism for metastatic colonization. As the latter is the rate-limiting step in the metastatic process, evaluation of the E-cadherin expression pattern could have potential therapeutic implications.
机译:目标。为了研究是否可以使用基于血液的标记物来识别具有淋巴结转移的前列腺癌患者。另外,在上皮间充质可塑性的概念内研究了E-钙粘着蛋白的表达。材料与方法。该研究纳入了75例临床局部PCa的患者,这些患者均接受了超大型淋巴结清扫术,然后进行了根治性前列腺切除术(RP)。术前血浆/血清内皮糖蛋白,转化生长因子-β1(TGF-β1),骨桥蛋白,血管内皮生长因子(VEGF),血管细胞粘附分子1(VCAM-1)和E-钙黏着蛋白的水平酶免疫法检测47/75例患者,并与临床病理参数相关。通过免疫组织化学分析检查了诊断性活检(n = 63),RP标本(n = 75)和LN转移灶(n = 106)中的E-钙粘蛋白表达。结果。几乎一半的患者(37/75)存在隐匿性LN转移,总共106个受影响的LN。术前内皮糖蛋白,TGF-β1,骨桥蛋白,VEGF,VCAM-1和E-钙粘蛋白的水平与LN状态显着相关。仅发现血浆内皮糖蛋白与血清前列腺特异性抗原之间呈正相关(Spearman r = 0.44; p = 0.002)。大部分活检样本(91.9%)和RP标本(79.7%)显示出强的E-钙粘着蛋白表达,而在LN中则被发现弱得多(28.9%)。尽管分离的肿瘤细胞(ITC)和微转移灶的染色模式主要是均一的,但宏观转移灶显示出更加异质的模式(χ2;, p <0.0001)。结论。在这项研究中,测试的所有基于血液的标记都不能用于PCa的淋巴结分期,也不能将E-钙粘蛋白在组织中表达。但是,ITC /微转移酶和大转移酶之间的E-钙粘蛋白表达模式的差异可能表明了另一种生物学行为。在大转移中看到的特定染色模式可能表明正在进行的间充质上皮转化,推测是转移性定植的机制。由于后者是转移过程中的限速步骤,因此评估E-钙粘蛋白表达模式可能具有潜在的治疗意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号